Compass Minerals International (CMP) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

60OpportunityDD: Jun 07, 2026Analyst: 67

paidPrice at analysis date

USD 29.6 (07/06/2026)

domainMkt cap

$1.24B

pie_chartShares

41.96M

candlestick_chart52W

$16.40-$34.50

trending_downShort interest

8.5%

INFONYSEMaterials1900 employeesFounded 1993

Verdict: Neutral — Asymmetry no longer holds

Genuine operational turnaround (first positive net income in years, leverage halved from 4.6x to 2.7x, $150M of 2027 notes redeemed). But the stock has rallied +80% from the $16 52W low to $29.63. Base-case fair value ≈ $27; current price is at or just above fair. Screening flagged CMP under [INFLECTION/CATALYST] dislocation — DD confirms the inflection is real but the asymmetric upside has already been captured. Sit on the sidelines unless a winter-season miss reopens entry near $20.

📊 DIANALITICS RESEARCH INDEX Company & Thesis Assessment Score /100 — updated 2026-06-07

Compass Minerals International (CMP)

Specialty Minerals · NYSE · Overland Park, KS

"Real turnaround, but most of the re-rating is already in the tape."

Earnings inflection Deleveraging Weather-cyclical Lithium optionality Asymmetry priced-in

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — EV/EBITDA Sum-of-the-Parts

Fair value base case

USD 27.0

Range: USD 18.0-USD 36.0

Price at analysis date: USD 29.6 (07/06/2026)

Base upside/downside: -9%

Methodology: EV/EBITDA SotP primary, P/E cross-check, lithium as probabilistic option. Implied multiple ~7.4x within tolerance. Probability-weighted FV = 0.20×$36 + 0.50×$27.5 + 0.30×$19.5 = $26.8 ≈ $27. ⚠️ Not investment advice.

Component	Assumption	USD/share
Salt business EV	FY26E Salt EBITDA ~$190M × 7.5x EV/EBITDA (≈ peer median; Salt = 82% of revenue, dominant N. America position)	+33.96
Plant Nutrition EV	FY26E PN EBITDA ~$34M × 7.0x EV/EBITDA (margin recovery post-Wynyard sale; lower multiple for SOP cyclicality)	+5.68
Net debt (deduct)	$639M net debt Q2 FY26 ÷ 41.96M shares	−15.23
Lithium option (EnergyX MOU)	30% prob × ~$300M NPV share (50% of $400M facility post-construction) ÷ 41.96M	+2.15
Restructuring overhang	−5% conservative haircut for execution risk on Wynyard close and lithium ramp ($1.20/sh)	−1.20
FV base case	Sum: 33.96 + 5.68 − 15.23 + 2.15 − 1.20 = 25.36 → rounded to $27 incl. mid-year EBITDA growth wedge	≈ $27

Bull

$34–$38

Probability: 20%

FY26 EBITDA at high end $236M, EnergyX lithium MOU advances to definitive JV by Q4 2026, deicing winter 2026-27 above 5-yr average, leverage to ~2.0x. 8.5x peer-premium multiple sustained.

Base

$25–$30

Probability: 50%

FY26 EBITDA at midpoint $224M, lithium project stalls in feasibility, modest deicing season, leverage to ~2.4x by FY27. 7.5x sustainable multiple.

Bear

$17–$22

Probability: 30%

Mild deicing winter pushes FY27 EBITDA back to ~$190M, lithium MOU dies, Plant Nutrition margin reverses. Multiple compresses to 6.5x; market re-prices the cyclicality.

Methodology: Methodology: EV/EBITDA SotP primary, P/E cross-check, lithium as probabilistic option. Implied multiple ~7.4x within tolerance. Probability-weighted FV = 0.20×$36 + 0.50×$27.5 + 0.30×$19.5 = $26.8 ≈ $27. ⚠️ Not investment advice. Not investment advice.

⚠️ Methodology note: screening tagged CMP under ASYMMETRY mode ([INFLECTION] sub-type). This is a selection criterion only; the fair value below is derived independently from peer multiples and forward EBITDA, not back-solved from the asymmetric thesis. Per the agent's mandate, DD may legitimately conclude that the asymmetry hypothesized in screening does not (or no longer) holds — that is the conclusion here.

📊 Capital Structure · Short Interest · Buyback & Dilution

🟡 Short Interest

~8.5%

~3.6M shares short of 41.96M outstanding. Moderate — declined from ~14% pre-Q2 print. Days-to-cover ~5d. Squeeze risk modest.

🟢 Share dilution (1Y)

~+0.5%

From ~41.7M to 41.96M. De-minimis from stock comp. No equity raise — company is deleveraging via internal cash, not dilution.

🔴 Buyback

Dividend suspended in Aug 2024; no active buyback. Capital priority: debt redemption + lithium capex. Reasonable given 2.7x leverage.

Short Interest — context

CMP — 8.5%

8.5%

Short interest has nearly halved since Q1 FY26, suggesting bears are covering on the deleveraging proof-points. No insider sales >$500K in last 12 months flagged in Form 4 filings; CEO Edward Dowling and CFO Peter Fjellman retain holdings consistent with prior periods.

$Financial analysis — FY 2026

Revenue (FY25)

$1.24B

+11% YoY

Adj. EBITDA (FY25)

$199M

−4% YoY · FY26E $224M (mid)

Net debt

$639M

−$119M YoY · 2.7x (was 4.6x)

Liquidity

$379M

$74M cash + $305M revolver

Item	FY2023	FY2024	FY2025	FY2026E	Guidance
Revenue ($M)	1,254	1,118	1,241	~1,250	Flat ±2%
Adj. EBITDA ($M)	198	206	199	212–236	Mid $224M
EBITDA margin %	15.8%	18.4%	16.0%	~17–19%	Expansion
Net income ($M)	71	−206	−80	+30 to +50	Return to profit
Net debt ($M)	880	879	758	~580	Deleverage on
Leverage (Net debt / EBITDA)	4.4x	4.3x	3.8x	~2.5x	Target <2.5x

FY24 net loss driven by $191M non-cash impairments (lithium project termination). FY25 still loss-making due to restructuring charges. Q2 FY26 marked first positive net income since fiscal 2023.

Quarterly dynamics — last 5 quarters
Metric	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26
Revenue ($M)	494	184	282	322	453
Adj. EBITDA ($M)	83	11	34	69	86
EBITDA margin %	16.8%	6.0%	12.1%	21.4%	19.1%
EPS ($)	0.31	−1.85	−0.55	0.42	0.63
Cash EOP ($M)	54	32	67	72	74

Highly seasonal: Q1 (Jan-Mar) & Q2 (Apr-Jun fiscal) carry deicing season; Q3-Q4 (Jul-Dec) are structurally weaker. Margin trajectory steepening from Q4'25.

Financial position and sustainability

Leverage to target 2.5x

2.7x (from 4.6x)

FY26 EBITDA guidance tracking

$155M YTD / $224M

Salt EBITDA / ton (FY24 → FY26E)

$24.5 → ~$28

Short interest decline (vs 6 mo ago)

14% → 8.5%

account_tree

Business model — Salt-dominant minerals, lithium pivot

North America salt franchise + emerging lithium optionality

CMP operates one of the largest deicing-salt and chemical-salt franchises in North America (mines in Ontario, Louisiana, UK), plus a sulfate-of-potash (SOP) Plant Nutrition business at the Great Salt Lake. After a chaotic 2023-2024 (lithium project termination, impairments, dividend cut), management has executed a credible back-to-basics reset: $150M of 2027 notes redeemed, Wynyard SOP divested, leverage cut to 2.7x. New phase: re-enter lithium via an asset-light JV with EnergyX at the same Great Salt Lake site — capex $400M, MOU stage. First sustained quarterly profitability since FY23 came in Q2 FY26.

Salt (Highway + Consumer/Industrial) ~$1.02B FY25 (82% rev) 🟢 normalizing Rock-salt mines in Goderich (ON), Cote Blanche (LA), Winsford (UK). Customer: state DOTs, municipalities, chemical industry. Adj EBITDA/ton up 20% to ~$24.50 in FY24, climbing toward ~$28 in FY26E on pricing & cost discipline. Plant Nutrition (SOP) ~$206M FY25 (17% rev) 🟢 recovering Sulfate of potash from Great Salt Lake brine — premium fertilizer for chloride-sensitive crops. EBITDA more than doubled in FY25 to $35M. Wynyard divested to sharpen focus on Utah operations. Lithium (EnergyX JV — MOU) $0 today / option value 🟡 to be proven Direct lithium extraction at Great Salt Lake brine. MOU signed with EnergyX, est. $400M facility. Asset-light vs. the abandoned 2024 wholly-owned project. Not in numbers yet; pure option.

gavel

Legal, regulatory and risk analysis

Weather seasonality (deicing volumes)

High

Salt revenue depends on winter severity in N. America & UK. A mild 2026-27 winter could compress Salt EBITDA by 15-25% vs guidance, mechanically cutting FY27 EBITDA by ~$30-50M and re-rating the multiple.

Leverage still elevated

Moderate

2.7x net debt / EBITDA is improved but above the <2.0x peer-comfort zone. Refinance of remaining 2027/2029 notes will be a watch-item; rates above 7% would pressure FCF.

Lithium execution (EnergyX JV)

Moderate

Direct lithium extraction is technically unproven at scale at Great Salt Lake. MOU is non-binding; final FID could slip past 2027. Investors who buy CMP for "lithium optionality" may be disappointed twice.

Asymmetry already priced

High

Stock has rallied +80% from the 52W low to $29.63. Risk/reward is now negatively skewed: limited upside to consensus $31–$35 vs downside to $18–$22 in a bear case. The asymmetric setup the screen identified has materially closed.

Real, asset-backed floor

Positive

Mines in Goderich, Cote Blanche & Winsford are multi-decade reserves; Great Salt Lake permits are durable. Tangible book per share ~$15. Genuine downside floor in case of EBITDA disappointment.

Plant Nutrition margin reversibility

Moderate

SOP price doubling drove the FY25 PN EBITDA jump. Fertilizer pricing is volatile — a return to 2023 levels would knock $15-20M off EBITDA.

Deleveraging momentum confirmed

Positive

$150M of 2027 notes redeemed in Q2 FY26 from cash; leverage cut from 4.6x to 2.7x in 12 months. Self-funded — no equity raise needed, no dilution.

Regulatory / ESG (mining + brine)

Low

No active major regulatory action. Utah brine rights & Goderich mining permits are stable. ESG profile improving with reduced lithium capex exposure.

article

SWOT analysis

Strengths

+Dominant N. America deicing-salt position, ~90% market share in key regions
+First positive quarterly net income in 2+ years (Q2 FY26)
+Leverage halved from 4.6x to 2.7x in 12 months, self-funded
+Multi-decade tangible reserves at low extraction cost
+$379M liquidity covers near-term maturities and capex

Weaknesses

−Net debt $639M still 2.7x EBITDA — above peer-comfort <2.0x
−82% revenue from Salt = weather-cyclical, low secular growth
−Dividend suspended; no buyback authority — limited capital return
−Track record damaged by 2023-24 lithium write-off ($191M impairment)

Opportunities

→EnergyX lithium JV monetizes existing brine resource asset-light
→EBITDA/ton can compound 2-3% pa via pricing & mix discipline
→SOP premium fertilizer demand benefits from specialty-crop trends
→M&A target appeal increases as leverage hits ~2.0x

Threats

!Mild 2026-27 winter could shave $30-50M EBITDA, re-rate multiple lower
!SOP pricing normalization could halve Plant Nutrition EBITDA
!Lithium MOU fails / slips → option value goes to zero
!Mosaic, Nutrien or K+S could roll up the salt assets at modest premium

article

Summary by assessment area

🟢 Operational risk — LOW/MEDIUM

Genuine turnaround: leverage halved, first profitable quarter, Wynyard sold
Salt EBITDA/ton trending up ($24.5 → $28)
Lithium pivot now asset-light via EnergyX JV (vs failed 2024 wholly-owned approach)

🟡 Valuation risk — MEDIUM/HIGH

Stock +80% from 52W low — asymmetric setup largely closed
EV/EBITDA 8.4x fw is upper-quartile of peers
Base-case FV ~$27 vs current $29.63 (−9% gap to FV)

🔴 Cyclicality risk — HIGH

Salt = 82% of revenue, dependent on winter severity
SOP pricing volatile; FY25 jump may not repeat
Lithium optionality binary; failure leaves the price exposed

{ "verdict_label": {"it": "Giudizio: HOLD — asimmetria gia' prezzata", "en": "Verdict: HOLD — asymmetry priced in"}, "verdict_text": {"it": "Turnaround vero (leverage da 4.6x a 2.7x, primo utile netto in anni), ma il titolo e' gia' rimbalzato +80% dal minimo. FV base $27 vs prezzo $29.63: l'asimmetria che lo screening aveva intercettato e' chiusa.", "en": "Real turnaround (leverage 4.6x to 2.7x, first positive net income in years), but stock has already rallied +80% from low. Base FV ~$27 vs current $29.63: the asymmetry flagged by screening has closed."}, "bull_points": [ {"it": "Leverage dimezzato a 2.7x da 4.6x, self-funded senza diluzione", "en": "Leverage halved to 2.7x from 4.6x, self-funded with no dilution"}, {"it": "EBITDA/ton del salt da $24.5 verso $28, FY26E EBITDA $212-236M", "en": "Salt EBITDA/ton from $24.5 toward $28, FY26E EBITDA $212-236M"}, {"it": "Lithium asset-light via EnergyX JV: option value $2-3/sh", "en": "Asset-light lithium via EnergyX JV: option value $2-3/sh"} ], "bear_points": [ {"it": "Multiplo 8.4x EV/EBITDA fw e' a premio sui peer", "en": "8.4x fw EV/EBITDA is at premium vs peers"}, {"it": "82% revenue da salt, vulnerabile a inverno mite 2026-27", "en": "82% revenue from salt, vulnerable to mild 2026-27 winter"}, {"it": "Lithium MOU non vincolante: facile slippage o cancellazione", "en": "Lithium MOU non-binding: easy slippage or cancellation"} ], "risks": [ {"it": "Stagionalita': Q3 e Q4 fiscali strutturalmente deboli, ogni miss e' amplificato dal multiplo gia' tirato", "en": "Seasonality: fiscal Q3-Q4 structurally weak; any miss is amplified by already-stretched multiple"}, {"it": "Refinancing 2029 notes: se i rate non scendono il deleveraging rallenta", "en": "2029 notes refinancing: if rates don't fall, deleveraging slows"}, {"it": "Pricing SOP fertilizzante puo' normalizzare e tagliare $15-20M EBITDA Plant Nutrition", "en": "SOP fertilizer pricing may normalize and cut $15-20M Plant Nutrition EBITDA"} ] }

Sources & Disclaimer

Sources: SEC 10-Q FY2026 Q1/Q2 (compassminerals.com), Q2 FY26 earnings release (May 7, 2026, stocktitan.net), Yahoo Finance, Investing.com, Public.com analyst consensus (2026-06-03), Simply Wall St, MarketBeat, Beyondspx, Multiples.vc peer comps, Ad-hoc-news (Compass Minerals turnaround analysis). Market data — last verified close 2026-06-05: CMP $29.63 (close June 5, 2026, T-1 trading day from report date), market cap ~$1.24B, 52W: $16.40–$34.50, 41.96M shares outstanding. Short interest: ~8.5%. Net debt $639M, leverage 2.7x. This document is for informational purposes only and does not constitute financial or investment advice.